Product
CRISPR/Cas9 mRNA
1 clinical trial
1 indication
Indication
Primary Open Angle GlaucomaClinical trial
A Clinical Study on CRISPR/Cas9 Instantaneous Gene Editing Therapy to Primary Open-angle Glaucoma With Elevated Intraocular Pressure and MYOC Gene MutationStatus: Recruiting, Estimated PCD: 2025-12-01